The effect of peppermint tablet on prevention of postoperative nausea and vomiting in inguinal hernia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017081332205N1

Enrollment

Registered

2017-08-13

Start date

2016-08-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patient Under Anesthesia. Unilateral or unspecified inguinal hernia, without obstruction or gangrene

Interventions

Intervention 1: In the control group, one placeboisotrophy isoseda company 30 minutes to 45 minutes before surgery and one other tablet of the same 3 hours after surgery, if complete consciousness an

Prevention

In the control group, one placeboisotrophy isoseda company 30 minutes to 45 minutes before surgery and one other tablet of the same 3 hours after surgery, if complete consciousness and airways reflex

In the intervention group, one tablet from Isooda company 30 minutes to 45 minutes before the surgery, and one other tablet of the same 3 hours after the surgery, if complete consciousness and airwa

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Entry Criteria: 1- Having a minimum age of 18 years and a maximum of 65 years of age; 2- Perform general anesthesia with intubation; 3- Underlying surgical procedure for inguinal hernia; 4- Non-allergenic to peppermint; 5-Gastrointestinal criteria: no wounds or inflammation, no history of gastric reflux, no biliary dysfunction, no bowel obstruction, no digestive tract ulceration, history of nausea and vomiting after the previous operation, no addiction to alcohol; 6- Cardiovascular system: Having ASA class (I, II) ; 7-Nervous system: Not having Alzheimer's disease and Parkinson's disease, not having internal ear disorders and migraines, history of travel sickness (seeing or riding) or vertigo; 8- Respiratory system: Absence of respiratory disease; 9- Fertility and lactation: Not pregnancy, lactation, absence of menstruation; 10- Endocrine: Absence of diabetes; Exit criteria: 1- Failure to protocol of anesthesia; 2.- Length Duration of anesthesia less than 30 minutes and more than 120 minutes ; 3- Receiving dexamethasone, hydrocortiizon or anti-nausea drug before or during anesthesia.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Nausea & Vometing. Timepoint: Preoperation & Postoperation for 6 Hour. Method of measurement: Visual Scale Nausea & Vometing.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBorabadi Mohamad

Sabzevar University of Medical Sciences

borabadi77@gmail.com+98 51 4401 1000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026